Cargando…

Interpreting Overdiagnosis Estimates in Population-based Mammography Screening

Estimates of overdiagnosis in mammography screening range from 1% to 54%. This review explains such variations using gradual implementation of mammography screening in the Netherlands as an example. Breast cancer incidence without screening was predicted with a micro-simulation model. Observed breas...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Gelder, Rianne, Heijnsdijk, Eveline A. M., van Ravesteyn, Nicolien T., Fracheboud, Jacques, Draisma, Gerrit, de Koning, Harry J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2011
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132806/ https://www.ncbi.nlm.nih.gov/pubmed/21709144 http://dx.doi.org/10.1093/epirev/mxr009

Ejemplares similares

Overdiagnosis and overtreatment of breast cancer: Microsimulation modelling estimates based on observed screen and clinical data
por: de Koning, Harry J, et al.
Publicado: (2006)

Detection and interval cancer rates during the transition from screen-film to digital mammography in population-based screening
por: Sankatsing, Valérie D. V., et al.
Publicado: (2018)

Finding the optimal mammography screening strategy: A cost‐effectiveness analysis of 920 modelled strategies
por: Kregting, Lindy M., et al.
Publicado: (2022)

Reply to: Comments on “Finding the optimal mammography screening strategy: A cost‐effectiveness analysis of 920 modeled strategies”
por: Kregting, Lindy M., et al.
Publicado: (2022)

Population-based mammography screening below age 50: balancing radiation-induced vs prevented breast cancer deaths
por: de Gelder, R, et al.
Publicado: (2011)

Extending Age Ranges in Breast Cancer Screening in Four European Countries: Model Estimations of Harm-to-Benefit Ratios
por: Zielonke, Nadine, et al.
Publicado: (2021)

Overcoming barriers: Modelling the effect of potential future changes of organized breast cancer screening in Italy
por: Zielonke, Nadine, et al.
Publicado: (2023)

Prediction of higher mortality reduction for the UK Breast Screening Frequency Trial: a model-based approach on screening intervals
por: van Ravesteyn, N T, et al.
Publicado: (2011)

Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
por: Vickers, Andrew J, et al.
Publicado: (2014)

Overdiagnosis in screening mammography in Denmark: population based cohort study
por: Njor, Sisse Helle, et al.
Publicado: (2013)

The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening
por: van Luijt, P. A., et al.
Publicado: (2016)

Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study
por: Autier, Philippe, et al.
Publicado: (2017)

Prostate-Specific Antigen Screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer–Rotterdam
por: Wever, Elisabeth M., et al.
Publicado: (2010)

The potential of breast cancer screening in Europe
por: Zielonke, Nadine, et al.
Publicado: (2020)

Effect of screening mammography on breast cancer mortality: Quasi‐experimental evidence from rollout of the Dutch population‐based program with 17‐year follow‐up of a cohort
por: Van Ourti, Tom, et al.
Publicado: (2019)

Overdiagnosis among women attending a population-based mammography screening program
por: Falk, Ragnhild Sørum, et al.
Publicado: (2013)

Experiences, expectations and preferences regarding MRI and mammography as breast cancer screening tools in women at familial risk
por: Geuzinge, H. Amarens, et al.
Publicado: (2021)

Overdiagnosis in organised mammography screening in Denmark. A comparative study
por: Jørgensen, Karsten J, et al.
Publicado: (2009)

Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality
por: Chang, Yaojen, et al.
Publicado: (2012)

Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends
por: Jørgensen, Karsten Juhl, et al.
Publicado: (2009)

Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy
por: Paci, Eugenio, et al.
Publicado: (2006)

Mammography screening in the Netherlands: delay in the diagnosis of breast cancer after breast cancer screening
por: Duijm, L E M, et al.
Publicado: (2004)

Cost‐effectiveness of multiparametric magnetic resonance imaging and MRI‐guided biopsy in a population‐based prostate cancer screening setting using a micro‐simulation model
por: Getaneh, Abraham M., et al.
Publicado: (2021)

Decreased rates of advanced breast cancer due to mammography screening in The Netherlands
por: Fracheboud, J, et al.
Publicado: (2004)

Complexities in the estimation of overdiagnosis in breast cancer screening
por: Duffy, S W, et al.
Publicado: (2008)

To be screened or not to be screened? Modeling the consequences of PSA screening for the individual
por: Wever, E M, et al.
Publicado: (2012)

The Early Detection of Breast Cancer Using Liquid Biopsies: Model Estimates of the Benefits, Harms, and Costs
por: van der Poort, Esmée K. J., et al.
Publicado: (2022)

The EU-TOPIA evaluation tool: An online modelling-based tool for informing breast, cervical, and colorectal cancer screening decisions in Europe
por: Gini, Andrea, et al.
Publicado: (2021)

Overdiagnosis and overtreatment of breast cancer: Estimates of overdiagnosis from two trials of mammographic screening for breast cancer
por: Duffy, Stephen W, et al.
Publicado: (2005)

Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40 to 49 in the United Kingdom
por: Gunsoy, Necdet B, et al.
Publicado: (2012)

Estimation of lead time and overdiagnosis in breast cancer screening
por: Gøtzsche, P C, et al.
Publicado: (2009)

Cost-Effectiveness of Magnetic Resonance Imaging Screening for Women With Extremely Dense Breast Tissue
por: Geuzinge, H Amarens, et al.
Publicado: (2021)

Overdiagnosis from non-progressive cancer detected by screening mammography: stochastic simulation study with calibration to population based registry data
por: Seigneurin, Arnaud, et al.
Publicado: (2011)

Mammography Facility Characteristics Associated With Interpretive Accuracy of Screening Mammography
por: Taplin, Stephen, et al.
Publicado: (2008)

Effects of cancer screening restart strategies after COVID-19 disruption
por: Kregting, Lindy M., et al.
Publicado: (2021)

The comparative effectiveness of mpMRI and MRI-guided biopsy vs regular biopsy in a population-based PSA testing: a modeling study
por: Getaneh, Abraham M., et al.
Publicado: (2021)

Correction: Effects of cancer screening restart strategies after COVID-19 disruption
por: Kregting, Lindy M., et al.
Publicado: (2021)

Overdiagnosis and overtreatment of breast cancer: Overdiagnosis and overtreatment in service screening
por: Paci, Eugenio, et al.
Publicado: (2005)

Which Strategies Reduce Breast Cancer Mortality Most?: Collaborative Modeling of Optimal Screening, Treatment, and Obesity Prevention
por: Mandelblatt, Jeanne, et al.
Publicado: (2013)

Overdiagnosis: epidemiologic concepts and estimation
por: Bae, Jong-Myon
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_176bkhp1qi4hoag2mki9ph3iq8